These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemically defined generation of human cardiomyocytes. Burridge PW; Matsa E; Shukla P; Lin ZC; Churko JM; Ebert AD; Lan F; Diecke S; Huber B; Mordwinkin NM; Plews JR; Abilez OJ; Cui B; Gold JD; Wu JC Nat Methods; 2014 Aug; 11(8):855-60. PubMed ID: 24930130 [TBL] [Abstract][Full Text] [Related]
6. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Karakikes I; Ameen M; Termglinchan V; Wu JC Circ Res; 2015 Jun; 117(1):80-8. PubMed ID: 26089365 [TBL] [Abstract][Full Text] [Related]
7. Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes. Burridge PW; Metzler SA; Nakayama KH; Abilez OJ; Simmons CS; Bruce MA; Matsuura Y; Kim P; Wu JC; Butte M; Huang NF; Yang PC Am J Transl Res; 2014; 6(6):724-35. PubMed ID: 25628783 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Ebert AD; Kodo K; Liang P; Wu H; Huber BC; Riegler J; Churko J; Lee J; de Almeida P; Lan F; Diecke S; Burridge PW; Gold JD; Mochly-Rosen D; Wu JC Sci Transl Med; 2014 Sep; 6(255):255ra130. PubMed ID: 25253673 [TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Burridge PW; Li YF; Matsa E; Wu H; Ong SG; Sharma A; Holmström A; Chang AC; Coronado MJ; Ebert AD; Knowles JW; Telli ML; Witteles RM; Blau HM; Bernstein D; Altman RB; Wu JC Nat Med; 2016 May; 22(5):547-56. PubMed ID: 27089514 [TBL] [Abstract][Full Text] [Related]
10. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies. Tzatzalos E; Abilez OJ; Shukla P; Wu JC Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619 [TBL] [Abstract][Full Text] [Related]
11. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077 [TBL] [Abstract][Full Text] [Related]
12. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. Sanchez-Freire V; Lee AS; Hu S; Abilez OJ; Liang P; Lan F; Huber BC; Ong SG; Hong WX; Huang M; Wu JC J Am Coll Cardiol; 2014 Aug; 64(5):436-48. PubMed ID: 25082575 [TBL] [Abstract][Full Text] [Related]
16. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. Sharma A; Li G; Rajarajan K; Hamaguchi R; Burridge PW; Wu SM J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867738 [TBL] [Abstract][Full Text] [Related]
17. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. Wang Y; Liang P; Lan F; Wu H; Lisowski L; Gu M; Hu S; Kay MA; Urnov FD; Shinnawi R; Gold JD; Gepstein L; Wu JC J Am Coll Cardiol; 2014 Aug; 64(5):451-9. PubMed ID: 25082577 [TBL] [Abstract][Full Text] [Related]